Main Article Content


Even though the process of vaccine licensure is rigorous, vaccines meant to protect individuals and populations may result in Adverse Events Following Immunization (AEFIs). An AEFI, is any untoward medical occurrence that follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The AEFIs have the potential to derail a vaccination programme if not handled professionally. The WHO makes it mandatory for the Expanded Programme on Immunization to work with the Food and Drugs Authority to implement a robust AEFI surveillance system. This is to detect, correct, and prevent AEFIs caused by errors in vaccine preparation, handling, storage, or administration and to allay fears due to false alarms. This study aimed to evaluate the AEFI surveillance system of the Kumasi Metropolis to determine whether it was meeting its objective, describe its attributes, and assess its usefulness from 2016 to 2020.  A descriptive cross-sectional design was used, based on the updated CDC guidelines for evaluating public health surveillance systems. A semi-structured questionnaire was used to collect data from health workers and caregivers within the Kumasi metropolis. Purposive sampling was adopted. Records were also reviewed. Excel pivot tables were used for analysis. In all, 21 health staff and 16 caregivers were interviewed. Knowledge among health workers and willingness to contribute to the system was high. All staff interviewed knew AEFI. The AEFI reporting forms were available. Between 2016 and 2020, 15 AEFI cases had been reported with no feedback officially received from the Technical Advisory Committee. More than 93% (15/16) of caregivers confirmed experiencing non-serious AEFIs in their children but never reported them. Knowledge among health workers was high, though the system was not meeting most of its objectives. The system was acceptable among health workers, unlike among caregivers. It was not sensitive enough, though stable, flexible, and representative.  Since the system failed to meet its objectives, it was not fully useful. We recommend that the Technical Advisory Committee sends prompt feedback on AEFIs. The case definition could also be reviewed to target AEFIs that may be of concern to caregivers only. Caregivers should be continuously educated on AEFIs.


Adverse Events Immunization Kumasi Surveillance System Evaluation

Article Details

How to Cite
Ampratwum, K. A., Asante, R., & Gyimah Omar-Sasu, A. (2023). Adverse Events Following Immunization (AEFI) Surveillance System Evaluation, 2016-2020 Kumasi Metropolis. International Journal of Multidisciplinary Studies and Innovative Research, 11(4), 1588–1600.


  1. Aborigo, R. A., Welega, P., Oduro, A., Shaum, A., Opare, J., Dodoo, A., Ampadu, H. H., & Jane F. Gidudua. (2022). Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: A qualitatitive study in four regions. PLoS One, 17(12).
  2. Armitage, R. (2021). Online “anti-vax” campaigns and COVID-19: censorship is not the solution. Public Health, 190.
  3. Benoit, S. L., & Mauldin, R. F. (2021). The anti-vax movement: a quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health, 21(2106).
  4. Epidemiology Unit, & Sri-Lanka MOH. (2012). National Survey on Surveillance of Adverse Events Following Immunization in Sri Lanka.
  5. FDA, & Ghana Health Service / Expanded Programme on Immunisation. (2014). Guidelines for Surveillance on Adverse Events following Immunisation in Ghana.
  6. Ghana Health Service /Ministry Of Health. (2020). Technical Guidelines for Integrated Disease Surveillance and Response In Ghana.
  7. Gidudu, J. F., Shaum, A., Dodoo, A., Bosomprah, S., Bonsu, G., Amponsah-Achiano, K., Darko, D. M., Sabblah, G., Opare, J., Nyaku, M., Owusu-Boakye, B., Oduro, A., Aborigo, R., Conklin, L., Welega, P., & Ampadu, H. H. (2020). Barriers to healthcare workers reporting adverse events following immunization in four regions of Ghana. Vaccine, 38(5).
  8. Kumasi Metro Health Directorate. (2020). Annual Report.
  9. Laryea, E. B., Frimpong, A. F., Noora, C. L., Tengey, J., Delia, B., Sabblah, G., Ameme, D., Kenu, E., & Amponsah Achiano, K. (2022). Evaluation of the Adverse events following immunization surveillance system, Ghana, 2019. Plos One, 17(3).,pone.0264697
  10. Lei, J., Ram, M., Gidudu, J. F., & Zuber, P. L. F. (2018). Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000 – 2015 q. Vaccine, 36(12), 1577–1582.
  11. Malande, O. O., Manube, D., Afaayo, R. N., Chemweno, C., Nzoka, M., Kipsang, J., Musyoki, A. M., Meyer, J. C., Omayo, L., & Owino-Okongo, L. (2021). Adverse events following immunization reporting and impact on immunization services in Nairobi, Kenya: a prospective mixed-methods study. Pan African Medical Journal, 40(81).
  12. Mutata, C., Cremance, T., Juru, T. P., Shambira Gerald, Tafara, G. N., Nsubuga, P., & Tshimanga, M. (2018). Evaluation of the adverse events following immunization surveillance system in Guruve district, Mashonland Central 2017. The Pan, 31(202).
  13. Omoleke, S. A., Bamidele, M., & C, de K. L. (2023). Barriers to optimal AEFI surveillance and documentation in Nigeria:Findings from a qualitative survey. Plos Global Public Health, 3(9).
  14. Singh, K., & Metha, S. (2016). The clinical development process for a novel preventive vaccine: An overview. Journal Of Postgraduate Studies, 62(1), 4–11.
  15. WHO. (2018). Global Vaccine Safety: Adverse Events following Immunisations.
  16. WHO. (2021). Module 5: National AEFI Surveillance Systems. Vaccine Safety Basics E-Learning Course.
  17. Zvanaka, S., Juru, T., Chonzi, P., Shambira, G., Gombe, N. T., & Tshimanga, M. (2017). Evaluation of the adverse events folowing immunizations surveillance system in Harare City, Zimbabwe 2016: a descriptive cross secional study. The Pan African Medical Journal, 28(308).